Uncategorized

$WTER 420 with CNW – Medical Marijuana May Be Future Treatment for Alcoholism

Research carried out by the School of Public Health and Social Policy at the University of Victoria along with the Canadian Institute for Substance Abuse Research revealed that people who used medical marijuana experienced a decline in their alcohol consumption.

The study involved 1,000 medical marijuana patients in Canada and examined them on their habits, which included questions on their alcohol consumption. The study’s findings revealed a decline in alcohol use.

The study asserted that marijuana can affect the use of other psychoactive substances, including illicit drugs, tobacco, alcohol and prescription medications. However, little research has been conducted that looks into the factors linked to these changes in substance use.

During the study, 18% of the individuals who were polled reported that they abstained from alcohol, 85% claimed that they decreased the drinks they consumed every week and 44% reported a decline in the frequency of their alcohol consumption as they used medical marijuana.

From the Canadian medical marijuana program, a sample of 2,102 individuals provided their data, with each individual giving answers based on their medical marijuana use throughout the study and how it affected their alcohol consumption. More than 970 respondents who used alcohol at least 10 times over a year before starting to use medical marijuana were also included in the study. The researchers then assessed retrospective data on amount of alcohol and the frequency of use before and after medical marijuana initiation.

It is estimated that about 107 million people around the globe suffer from alcohol use disorder. This is a physical and mental addiction that’s common. The use of marijuana/medical marijuana to help decrease alcohol use is good news for many. Additionally, the WHO reports that marijuana is 114 times safer than alcohol, with alcoholism killing 3 million individuals around the globe annually.

The study findings suggest that the use of medical marijuana may be linked to reductions in alcohol intake and cessation among medical marijuana patients. Liquor is the most common recreational substance in North America, and it has high rates of mortality, morbidity and criminality as a result of its use. The authors of the study claim that these findings may bring about better health outcomes for medical marijuana patients and improve general safety and public health as well.

While this is only one study that looks into the link between the use of alcohol and medical marijuana, it may be the key to more research that supports marijuana treatment as a way to keep off liquor.

A company worthy of your attention in the cannabis industry is The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER). The company focuses on using innovative proprietary electrolysis processes to make perfectly balanced alkaline water as well as CBD-infused eats and drinks.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Monday, November 16th, 2020 Uncategorized Comments Off on $WTER 420 with CNW – Medical Marijuana May Be Future Treatment for Alcoholism

$SGTM As Millennials Drive Socially Responsible Investing, Sustainable Green Team Offers Ethical, Profitable Investment Opportunity

November 16, 2020
  • Survey suggest over 60% of millennials willing to accept lower returns if an investment is sustainable, 83% considering transitioning entire pension into sustainable portfolio
  • SGTM produces environmentally beneficial products using natural waste created by hurricanes and storms while preventing burdens on municipal landfills
  • SGTM recorded 794% increase in revenue and 4,817% increase in gross profit compared to all of 2019, preparing for future uplisting

Discretionary spending across almost all sectors has taken a dive in recent months as the global recession deepens. Despite the negative performance across many consumer goods and service sectors, some businesses continue to survive – and even thrive. Among them is Sustainable Green Team (OTC: SGTM), a leading provider of solutions for tree and storm waste disposal that turns problems into profits through the transformation of natural waste into products that benefit the environment.

Awareness around sustainable investing appears to be increasing, particularly among millennials who appear to be driving the movement. A recent survey suggests that over 60% of investors within this age group would accept lower returns if an investment is ethical while 83% are considering transitioning their entire pension into a sustainable portfolio (https://ibn.fm/zDXtA).

“You do not have to sacrifice returns when investing in a socially responsible portfolio,” said Jamie Broderick, Impact Investing Institute & former UK CEO of UBS Wealth Management. “There are several different categories along the spectrum of capital, and you can choose how you’d like to invest in line with your values, whether in line with market returns, or on a concessionary basis.”

SGTM provides an opportunity for investors to take part in a sustainable business with significant growth potential. Through its subsidiaries, the company provides tree services that include debris hauling, debris removal, biomass recycling, mulch and playground surface material manufacturing, product packaging and sales. Founded in sustainability and based on vertically integrated operations, the company takes its role as a steward of the environment seriously by diverting this natural material from landfills and transforming it into a variety of organic, attractive, next-generation products that benefit the natural landscape.

SGTM’s expansion plans include organic growth strategies, national partnerships and strategic acquisitions. Following a busy storm season that included Hurricane Laura relief efforts, the company was awarded a string of contracts with large companies that included The Kroger Co., Circle K, 7-Eleven, Old Castle Lawn & Garden, Menards Inc., and many more. The company has commenced the FORM-10 process to become fully reporting and, in anticipation of a future uplisting, disclosing a massive 794% increase in revenue and a 4,817% gross profit increase in the first half of 2020 when compared to all months in 2019 combined (https://ibn.fm/0EG3C).

Along with its stellar financial results, SGTM’s impressive overall performance is a testament to the expertise of its management, bolstered by over 40 years of next-level experience across all the company’s verticals. It may not make front page news or create a buzz like electric vehicles or biotech innovation, but the work carried out by SGTM makes a positive impact that directly improve the lives of citizens in the communities the company serves – all while sharing the profits with its loyal group of investors.

To learn more about Sustainable Green Team Ltd., view the investor presentation at https://ibn.fm/l1Pgk.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, November 16th, 2020 Uncategorized Comments Off on $SGTM As Millennials Drive Socially Responsible Investing, Sustainable Green Team Offers Ethical, Profitable Investment Opportunity

$SGTM Announces Engagement of Anthony L.G. PLLC

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, today announced that it has engaged Anthony L.G. PLLC to initiate the FORM-10 process to become fully reporting, uplist and assist with all SEC legal matters. According to the update, the engagement was made shortly after the company’s wholly owned subsidiary, Mulch Manufacturing, expanded its 2021 mulch contracts with Circle K convenience stores, a subsidiary of Alimentation Couche-Tard Inc. (OTC: ANCUF). “We have communicated with many firms since our audit completion to see whom would be best suited for our team, shareholders, and transpire our vision,” said SGTM’s CEO and Director Tony Raynor. “After communicating with Laura Anthony and doing our due diligence, our team feels more confident than ever on achieving our ultimate goal to be listed on the NASDQ to maximize exposure and greater value.”

To view the full press release, visit http://ibn.fm/qSXnY

About Sustainable Green Team Ltd.

Sustainable Green Team, through its subsidiaries, provides tree services, debris hauling and removal, biomass recycling, mulch manufacturing, packaging and sales. The company was established with the objective of providing a solution for the treatment and handling of tree debris that has historically been disposed of in landfills, creating an environmental burden and pressure on disposal sites around the nation. The company’s solutions are founded in sustainability, based on vertically integrated operations that begin with collecting of tree debris through its tree services division and collection sites, then, through its processing division, recycling and using that tree debris as a feedstock that is manufactured into a variety of organic, attractive, next-generation mulch products that are packaged and sold to landscapers, installers and garden centers. The company plans to expand its operations through a combination of organic growth and strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified. The company’s customers include governmental, residential, and commercial clients. For information regarding SGTM’s operations, expansion plans and production facilities, visit http://ibn.fm/NYk36

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, November 16th, 2020 Uncategorized Comments Off on $SGTM Announces Engagement of Anthony L.G. PLLC

$SRAX Announces 161% YoY, 124% QoQ Revenue Growth

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights to publicly traded companies through Sequire, announced results for the three months ended September 30, 2020. Among the highlights, the company reported $2.6 million in total revenue for Q3, which represents 161% year-over-year (“YoY”) and 124% sequentially quarter-over-quarter (“QoQ”) growth. “As the Sequire platform continues to grow and adapt to customer needs, we are seeing a tremendous increase in our recurring revenue stream,” said Chris Miglino, founder and CEO of SRAX. “Sequire is changing the way public issuers interact with and engage their investors, and it shows. We are pleased to report our first quarter of positive EBITDA from our Sequire segment.”

To view the full press release, visit http://ibn.fm/po8vK

About SRAX Inc.

SRAX is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information about the company, visit www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, November 16th, 2020 Uncategorized Comments Off on $SRAX Announces 161% YoY, 124% QoQ Revenue Growth

$PCSA Announces Participation Schedule for Upcoming Investor Conferences

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, today announced that management will participate in two upcoming investor conferences. According to the update, Processa will participate in one-on-one meetings at the Craig-Hallum Alpha Select Virtual Conference on Tuesday, Nov. 17, 2020, and the Benchmark Annual Discovery 1×1 Investor Virtual Conference on Wednesday, Nov. 18, 2020. Interested parties should contact their conference representative or James@HaydenIR.com to schedule a one-on-one meeting with management.

To view the full press release, visit http://ibn.fm/biHn2

About Processa Pharmaceuticals Inc.

The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options that improve survival and/or quality of life. The company used these criteria for selection to further develop its pipeline programs to achieve high-value milestones effectively and efficiently. Active pipeline programs include: PCS6422 (metastatic colorectal cancer and breast cancer), PCS499 (ulcerative necrobiosis lipoidica) and PCS12852 (GI motility/gastroparesis). The members of the Processa development team have been involved with more than 30 drug approvals by the FDA (including drug products targeted to orphan disease conditions) and more than 100 FDA meetings throughout their careers. For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at http://ibn.fm/PCSA

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Monday, November 16th, 2020 Uncategorized Comments Off on $PCSA Announces Participation Schedule for Upcoming Investor Conferences

$PBIO to Discuss Third Quarter 2020 Financial Results and Provide Business Update

Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”) today announced that the Company will host a teleconference to discuss its Third Quarter 2020 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay (by telephone or via a link on the Company’s website) approximately one day after the teleconference.

The teleconference will include a Company presentation followed by a Question & Answer period.

Date:  Tuesday, November 17, 2020.
Time:  4:30 PM Eastern Time (ET).

To attend this teleconference, live by telephone: Dial-in: (877) 407-8033 ( North America ); (201) 689-8033 (International). Verbal Passcode: PBI Third Quarter 2020 Financial Call & Business Update.

For those unable to participate in the live teleconference, a replay will be available beginning Wednesday, November 18 , 2020.  The replay will be accessible via telephone and the Company’s website for 30 days.

Replay Number: (877) 481-4010 ( North America ); (919) 882-2331 (Int’l); Replay Passcode: 38901.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control biomolecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired, patented technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

For more information about PBI and this press release, please click on the following link: http://www.pressurebiosciences.com

Monday, November 16th, 2020 Uncategorized Comments Off on $PBIO to Discuss Third Quarter 2020 Financial Results and Provide Business Update

$POAI CEO Discusses Subsidiaries’ Proprietary Tech, Innovative Media

  • CEO expects results that will “build the stock and raise the stock price”
  • POAI focused on positioning TumorGenesis kits to manufacturers
  • Helomics has largest database of its kind in the world, brings cutting-edge technology to cancer research

During a recent NetworkNewsWire exclusive audio interview, Predictive Oncology (NASDAQ: POAI) CEO Carl Schwartz noted recent company milestones and outlined strategic goals. In addition, Schwartz provided key updates on the company’s four impressive subsidiaries: Skyline Medical, TumorGenesis, Soluble Biotech and Helomics.

“I’m very encouraged. I think we’re moving right along. Things never go as fast as we would like them, and it can be very frustrating at times,” Schwartz stated. “We have a lot going on, and we’re working hard on our goals. . . . We expect results that will be advantageous to the company and that will build the stock and raise the stock price.”

During the interview, Schwartz noted that the original purpose of TumorGenesis was to develop a lab media to replace rats and mice in scientific industries as well as the testing of tumors. The company has succeeded in developing the first media: ovarian cancer.

“This media, which, as I said, replicates the body, fools the tumor into thinking it’s still in the body,” Schwartz explained. “Its reactions are very, very similar to what it would have done had it been in the body. Now the next step is to get it positioned to manufacturers and getting the kits out so people can use it. That’s coming along handsomely.”

Schwartz also talked about POAI’s newest subsidiary, Soluble Biotech, which is essentially the combination of two labs. “We moved them now into a research park,” he said. “We quadrupled the space that they have, and they have the latest in equipment. The technology used by Soluble is proprietary. These machines that we have were developed some time ago and are the only machines of their kind. In the determination of solubility of products, they work wonders in that area. We expect, going forward, that they’ll get a number of contracts.”

Finally, Schwartz noted that POAI has positioned Helomics to compete in the marketplace. “The original basis of Helomics . . . was that physicians or hospitals would send their tumors to this company, and they would test the tumors with the known therapies of the day,” he said. “In that process, [Helomics] accumulated over 150,000 tumors covering over 137 different cancer.”

Schwartz noted that Helomics currently has the largest database of its kind in the world, and through its subsidiary, POAI brings cutting-edge technology to cancer research and works with the pharmaceutical, diagnostic and biotech industries to develop predictive models of how specific tumors may respond.

“With that data, and the fact that we’ve sequenced these tumors, we have shown that we can provide quality information to anyone who needs it,” he continued. “There’s a lot going on at Helomics. We think we’ve validated the company. We’ve got assets that are one-of-a-kind in the world, and we think we are on our way to where we wanted to be when we first purchased this company a couple of years ago.”

Predictive Oncology operates through three segments (domestic, international and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions by providing an evidence-based road map for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners.

For more information, visit the company’s website at www.Predictive-Oncology.com

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Monday, November 16th, 2020 Uncategorized Comments Off on $POAI CEO Discusses Subsidiaries’ Proprietary Tech, Innovative Media

$NETE Announces Q3 2020 Financial Results

Net Element (NASDAQ: NETE), a global technology and value-added solutions group that supports electronic payments acceptance in a multichannel environment including point of sale (“POS”), e-commerce and mobile devices, today announced its financial results for the third quarter ended Sept. 30, 2020. Among the highlights for the quarter as compared to the same period in 2019, Net Element reported an increase in total transaction volume to $956.2 million versus $953.7 million, a decrease in net revenues to $16.7 million versus $16.8 million, as well as an increase in North American Transaction Solutions revenue to $16.07 million versus $15.9 million. “We continue working diligently in an effort to finalize the Mullen merger for the benefit of our shareholders,” said Oleg Firer, executive chairman of Net Element.

To view the full press release, visit http://ibn.fm/i7NfQ

About Net Element Inc.

Net Element operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. On Aug. 5, 2020, Net Element announced the execution of a definitive agreement (the “Merger Agreement”) to merge with privately-held Mullen Technologies Inc. (“Mullen”), a Southern California-based electric vehicle company in a stock-for-stock reverse merger in which Mullen’s stockholders will receive a majority of the outstanding stock in the post-merger company (the “contemplated merger”). That contemplated merger is subject to customary closing conditions, regulatory approvals and shareholder approval for both companies. For additional information, visit www.NetElement.com.

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Monday, November 16th, 2020 Uncategorized Comments Off on $NETE Announces Q3 2020 Financial Results

$NETE Switching to Sustainable Technologies Will Depend on Meticulous Planning

At the moment, many countries are pinning their plans of recovering from the pandemic-induced economic downturn on investments that will be directed towards developing or deepening green technologies, such as electric vehicles and renewable energy. However, the catchy phrases being flashed around will not help the world operate more sustainably if careful planning isn’t directed towards making the leap workable in the long term.

For example, making the switch to renewable forms of energy, such as solar and wind energy, to quickly can leave economies at the mercy of the fickle weather. This could have devastating consequences when not enough sunlight is available to capture solar power or when wind strengths are so low that wind turbines are unable to work.

Such supply shocks can easily make renewable energy prohibitively expensive, and that would make the dream of 100% sustainable energy undesirable and even unworkable.

A sudden total switch would also reveal how deficient countries around the world are in regards to mass storage capacity for the energy generated within the windows when ample sunlight or a sufficiently strong wind exists to generate electricity.

So, what is the way forward?

Now is the time to be real about the practical issues that may impede the dream of delivering or using sustainable technologies. For example, the public in many parts of the world isn’t yet fully sold on switching to electric vehicles because of a valid concern about the limited charging infrastructure available.

In the spirit of confronting head-on the challenges to a sustainable future, Cranfield University is working with the UK government to establish an app that will facilitate peer-to-peer trading of energy needed to charge EVs. The plan is to link EV owners with excess battery power to those who need it. The exchange can take place at cafes or charging stations which are privately owned.

Another example of the way in which the anticipated challenges of switching to renewable energy can be addressed is by developing drones that can enable tech teams to remotely monitor offshore wind farms. Currently, it is expensive and inefficient to send crews in chartered ships to provide information and to monitor these wind farms. By using drones to inspect the wind turbines, costs can go down and system reliability can be improved.

Such efforts can ensure that consumers can adjust their behavior and make better choices so that the way they collectively live undergoes a paradigm shift to more sustainable technologies.

Net Element (NASDAQ: NETE) is a company you ought to watch in the green energy space. Early in August, this global financial solutions firm announced that it was merging with a California-based EV manufacturer called Mullen Technologies Inc. All eyes are on how the new entity will fare in the electric vehicle space.

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Monday, November 16th, 2020 Uncategorized Comments Off on $NETE Switching to Sustainable Technologies Will Depend on Meticulous Planning

$DRIO Gene Marker Suggests Likelihood of Prostate Cancer Metastasizing

Researchers have found a genetic signature that can forecast whether cancer is likely to metastasize or spread in the early stages of localized prostate cancer. The signature can also predict whether the disease will respond to anti-androgen therapy. In addition, the new signature may be beneficial in helping evaluate the disease’s response to treatment as well as creating new treatments to treat or avert the advanced stages of prostate cancer. This groundbreaking study was reported in “Nature Cancer.”

A professor of cell biology and pathology in Columbia University’s Irving Medical Center, Cory-Abate-Shen, senior author of the study, states that if scientists could know beforehand which patients would develop metastases, this would enable them to begin treatments earlier and treat the disease more aggressively. The information would also be valuable for patients whose cancer is likely to remain restricted to the prostate as they could be spared unnecessary therapy.

In the United States, prostate cancer is the second-leading cause of cancer death in men. This year, it is estimated that approximately 33,330 men will succumb to the disease. Most prostate cancers do not spread to other areas, remaining in the prostate. These cancers can be managed successfully by local therapy such as radiotherapy or surgery or surveillance. Their five-year survival rates are over 99%. However, once prostate cancer spreads, survival rates reduce to about 30%, and the cancer is said to be incurable.

Associate research scientist in therapeutics and molecular pharmacology at Columbia University, Juan M. Arriaga, lead author of the study, states that it’s difficult to know which cancer is which, a problem that impacts the current tests being used. This challenge can lead to overtreating of cancers that grow slowly and that may not have spread; it can also contribute to missing aggressive cancers that could have been treated in good time.

The researchers used a mouse model to identify a more precise technique of forecasting advanced prostate cancer. They discovered that the molecular profile of bone metastases was different when compared to the molecular profile of primary tumors. This enabled the researchers to determine 16 different genes that prompt localized prostate cancer to spread.

The researchers note that the genetic signature, i.e., META-16, was extremely effective at predicting the time the disease would start spreading and if it would respond to anti-androgen therapy. This therapy is used to suppress the male hormone as it stimulates tumor progression. The new signature may, in theory, be used to create therapies that prevent metastatic prostate cancer. At this stage, the researchers are improving the test, with the hope that they’ll assess it in a future clinical trial.

DarioHealth Corp. (NASDAQ: DRIO) is a specialist in digital therapeutics and is a company you should watch. DarioHealth touts the use of artificial intelligence to deliver personalized user experience regarding its smartphone-based, chronic-disease management.

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Monday, November 16th, 2020 Uncategorized Comments Off on $DRIO Gene Marker Suggests Likelihood of Prostate Cancer Metastasizing

$CRTD Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2020

Creatd, Inc. (Nasdaq CM: CRTD) (“Creatd” or the “Company”), the parent company of Vocal, a proprietary technology platform for creators, today reported financial results for its three and nine-month periods ended September 30 , 2020.  The Company accomplished several milestones and financial goals during the third quarter of 2020, including up-listing to the Nasdaq Capital Market, as it readies its operations to deliver on its accelerated growth trajectory.

Key Third Quarter 2020 Highlights:

  • Reconstituted Creatd’s Board of Directors and appointed several new members:
    • Mark Standish , former co-CEO of RBC Capital Markets, was appointed Chairman of the Board in July as well as Chairman of the Audit Committee.
    • Mark Patterson , co-founder of a multi-billion private equity firm MatlinPatterson Global Advisors, joined the Board of Directors in July and was appointed Chairman of its Compensation Committee.
    • Laurie Weisberg , technology and data marketing executive (previously Chief Sales Officer of Intent, Chief Revenue Officer of Thrive Global and member of the executive leadership team of Datalogix through its $1.2 billion acquisition by Oracle) joined the Board of Directors in July.
    • LaBrena Jones Martin , a highly seasoned corporate and securities attorney (previously with SEC, E.F. Hutton, Shearson, Lehman Brothers, and RBC), joined the Board and was appointed Chair of its Nominating and Corporate Governance Committee, subsequent to the third quarter of 2020.
  • Up-listed to the Nasdaq Capital Market on September 11, 2020 , changed its name to Creatd, Inc., and effectuated a 3-for-1 reverse stock split.
  • In connection with the Nasdaq up-listing, the Company completed an underwritten public offering resulting in gross proceeds of approximately $7.8 million .
  • In September, the Company announced the appointment of Laurie Weisberg as Chief Operating Officer, in addition to her responsibilities as a member of the Board of Directors.
  • Development updates and optimization the Vocal platform in anticipation of the continuing increases in visitor volume and platform activity; upgraded internal management systems.
  • Surpassed third quarter revenues guidance by over 6%, generating approximately $425,000 , an increase of 32% over the second quarter 2020 and a more than four-fold increase compared to third quarter 2019. Management anticipates that fourth quarter revenue growth will match, if not exceed the growth achieved in the third quarter.
  • Reduced total liabilities from $15.5 million to $3.3 million during third quarter 2020 through conversion of notes and payables into equity as well as a $3.6 million cash payment towards multiple accrued payables and short-term debt.
  • Vocal Key Metrics:

9-30-2019

6-30-2020

9-30-2020

Current as of 11-15-2020

Content Creator Accounts – Freemium

485,780

642,539

714,165

810,000

Vocal+ – Paid subscriber Accounts

250

2,300

4,600

7,500

Vocal+ Subscriber Acquisition Cost (SAC)

$1,000

$350

$180

$170

Commenting on the third quarter, Jeremy Frommer , Creatd’s founder and CEO, said, “Just under four years ago, in December 2016 , we launched our proprietary platform Vocal, with less than 1,000 beta creators and six owned and operated digital communities. Our goal was to create a best-in-class technology platform that made it easy for creators of all types to share their stories and their experiences, get discovered, and be rewarded for their passions. Core to Vocal’s design are its storytelling tools. With its unparalleled editor, the creator has the ability to integrate already-published rich media such as videos, songs, and podcasts to reach niche communities and engage with their ideal audiences.”

Frommer continued, “Fast forward to today, we have been able to onboard over 800,000 freemium creators who have collectively published over 150 million words on Vocal, and attract nearly 10 million visitors monthly. These accomplishments were achieved with comparatively few development and marketing resources, compared to other privately funded creator platforms.  Now, with a significantly strengthened balance sheet, enhanced visibility from our listing on the Nasdaq Capital Market, and the collaboration of a powerful support network, we believe Creatd is prepared to scale revenues and that our Vocal platform is the driving force that will deliver profitability during fiscal year 2021.”

Creatd reported third quarter 2020 revenues of $425,000 , more than four-fold increase compared to revenues of $91,000 for the same period in the previous year and a 32% increase from the $323,000 in revenues reported for the second quarter of 2020. Of note, second quarter revenues of 2020 were 10% greater than the first quarter of 2020. The significant year-over-year increase in revenues is predominantly due to steady growth of Vocal+ paid subscribers and the rising price points for Vocal for Brands’ campaigns. Vocal+ came out of beta in early 2020 and, with little budgeted for marketing, grew to over 4,500 paying subscribers by the end of the third quarter.  Now, with an increase in marketing as a result of the Company’s equity financing in mid-September, Vocal+ subscribers are increasing in excess of 100 new subscribers per day, and maintaining current levels, should surpass the Company’s goal of reaching 10,000 paid subscribers by year end. As the number of paid Vocal+ subscribers continue to increase, subscriber acquisition costs (SAC) are expected to continue to decline. Currently, acquisition costs total less than $170 per subscriber, compared to costs of $350 per subscriber at the end of second quarter 2020 and over $1,000 per subscriber only one year ago at the end of third quarter 2019.

Vocal for Brands, which generated approximately 39% of the Company’s third quarter revenues, is experiencing growth in both brand customer count as well as individual campaign price increases.  Vocal for Brands grew revenues nearly 100% since the second quarter, with an over 25% increase in average contract price. Managed Services, vis a vis the Seller’s Choice agency, accounted for roughly 43% of revenues generated during the quarter.  While Managed Services revenues were essentially flat quarter over quarter, this business line saw an increase in new clients towards the end of September, which is expected to impact revenue starting in the fourth quarter, historically the best quarter for this business line.

Operating expenses for the three months ended September 30, 2020 totaled approximately $7,449,000 . This is over four times the operating expenses reported in third quarter 2019 and over two times that of the second quarter 2020. The increase in operating expenses primarily reflects non-recurring charges attributed to the Nasdaq up-listing and related financing activities, totaling approximately $1,200,000 , as well as $3,600,000 related to 400,000 performance-based stock options granted to management, that was required to be expensed entirely during the quarter.  These performance options represent over three years of catch-up options for 13 members of the management team, and are expected to vest in April 2021 . Going forward, the Company expects operating expenses to decrease materially, slightly offset by a measured increase in support staff focused on revenue growth.  Subsequent to quarter-end, Creatd increased its sales team from two to eight individuals, including several senior professionals with long-standing brand relationships. During the three-month period ended September 30, 2020 , the Company incurred a loss from operations of $(7,024,000) . This compares to a loss from operations of $(1,657,000) during the same period last year and a loss of $(3,535,000) during the second quarter 2020.

The Company incurred other (non-operational) expenses of $6,552,000 in the third quarter 2020, compared to $277,000 in the third quarter 2019, and $607,000 in the second quarter 2020. The increase in third quarter other (non-operational) expenses was due to an increase in non-recurring, non-cash charges for accretion of debt discount and issuance costs totaling approximately $6,371,000 , offset by other income of $438,000 related to a cash rebate the Company receives from its research and development subsidiary in Australia .

The Company reported a comprehensive loss of approximately $(13,570,000) , or $(3.20) per share, for the three months ended September 30, 2020 , compared to the previous year’s third quarter comprehensive loss of approximately $(1,934,000) , or $(0.65) per share, and a comprehensive loss of $(4,161,000) , or $(1.29) per share for the second quarter 2020.

For the nine months ended September 30, 2020 , the Company reported revenues of approximately $1,040,000 compared to revenues totaling approximately $133,000 for the same period in 2019.  With the continued development of our Vocal technology platform, a vastly improved balance sheet, and a newly expanded seasoned sales team, management anticipates reporting accelerated quarterly revenue growth for the foreseeable future.

Operating expenses for the nine months ended September 30, 2020 totaled $13,426,000 as compared to $4,897,000 for the nine-month period ended September 30 , 2019.  The increase in operating expenses predominantly reflects one-time expenses related to the Nasdaq up-listing, the underwritten public offering, and the debt conversion, as well as $1,400,000 of non-cash charges related to employee option exchange for stock during second quarter and $3,600,000 in three-year  catch-up performance-based stock options granted to 13 members of the management team during the third quarter. During the first nine months of 2020, our average monthly cash burn was approximately $559,000 per month, in line with previous years. Management expects this number to remain steady during the course of fiscal year 2021, barring any consideration of growth opportunities that could require additional expenditures in this period.

Interest expense during the first nine months of 2020 totaled $1,379,000 compared to $329,000 during the same period of 2019. Creatd reported a comprehensive loss for the nine months ended September 30, 2020 of $(20,726,000) or $(5.91) per share, which included a non-recurring, non-cash charge of $6,698,000 related to debt conversion to equity. This compares to a net loss of $(5,400,000) or $(2.05) per share for the same period in 2019.  Net cash used in operating activities during the first nine months of 2020 totaled $5,032,000 compared to $4,708,000 for the same period in 2019. Management expects future financing specifically to scale its customer acquisition and marketing campaigns.

Company Reduces Current Liabilities from $14.9 Million to $2.7 Million During Third Quarter 2020
On September 30, 2020 , the Company reported total assets of $5.7 million , which includes its wholly owned image library and related transmedia IP carried at zero value. The sequential quarter over quarter increase of approximately $3 million in total assets primarily reflects an increase in cash from remaining proceeds of the Company’s equity offering during the quarter.

Following the underwritten public offering resulting in approximately $7.8 million in gross proceeds ( $7.1 million net proceeds) on September 11, 2020 , the Company significantly reduced its total liabilities from $15.5 million as of June 30, 2020 to $3.3 million as of September 30 , 2020.  As Creatd has consistently carried little long-term debt since inception, the substantial portion of the decrease in liabilities was attributed to the conversion of notes, accrued interest, and payables totaling approximately $11,900,000 into the Company’s equity. Cash repayment of accrued payables and short-term debt totaling $3,600,000 accounted for the remainder of the current liability decrease.

As of September 30, 2020 , the Company’s non-current portion of debt totaled $578,000 , comprising $412,000 in the Government Payroll Protection Program (“PPP”) loan and $177,000 in operating leases payable. The company intends on requesting relief in accordance with SBA guidelines for the PPP loan. At September 30, 2020 the Company’s current liabilities totaled $2.7 million , which included approximately $174,000 in (mandatory) convertible notes, $105,000 in deferred revenue and unrecognized tax benefits, and $1.04 million in short term debt, of which approximately $660,000 is related to the acquisition of Seller’s Choice. The Company is currently in litigation regarding the note and continues to believe that the case lacks merit and has moved to dismiss.  The company has an appearance scheduled for November 19, 2020 and expects no major events to occur in regard to this litigation for the next 12 months. In the event this case is not summarily dismissed, the Company intends to vigorously challenge it.

As a result of the underwritten public offering and the debt conversion, the Company’s shares of common stock outstanding increased from 3.3 million as of June 30, 2020 to 8.7 million as of September 30 , 2020.  The Company’s fully diluted share count increased by approximately 8.07 million shares during the third quarter to approximately 12.4 million shares (inclusive of all options, warrants and convertible debt). The majority of the increase to the fully diluted share count was also due to the underwritten public offering and debt conversions, and includes 1.7 million share purchase warrants issued in conjunction with the offering, 900,000 warrants issued in conjunction with debt conversion, and 400,000 performance-based stock options granted to management of the Company that vest on April 1, 2021 and, as previously mentioned, were part of a three-year program.  If all outstanding options ( $23.67 average strike price) and warrants ( $5.63 average strike price) were exercised for cash, the Company would receive approximately $17.5 million in additional capital.

As of December 31, 2019 , the Company had federal and state tax loss carry forwards of approximately $21.0 million , which expire through the fiscal year ending December 31, 2033 .

Third Quarter 2020 Conference Call and Webcast Details:

Date/Time Tuesday, November 17, 2020 – 11:00 a.m. (Eastern Time)

Those interested in participating may access the webcast using the link below: https://event.on24.com/wcc/r/2830586/777DE409B84791B83212B43FD73A2CCB

It is recommended that participants join 15 minutes before the presentation is scheduled to begin. A recording of the webcast will be made available on the Company’s website following the session.

Contact: Press and Investor Relations
Rachel David
Head of Business Development and Communications
Creatd, Inc.
(201) 258-3770
rachel.david@creatd.com

About Creatd

Creatd, Inc. (Nasdaq CM: CRTD) empowers creators, brands, and entrepreneurs through technology and partnership. Its flagship technology platform is Vocal; Vocal provides creators of all shapes and sizes, from bloggers to podcasters, and more, with best-in-class storytelling tools, safe and curated communities, and the opportunity to monetize their content. With 34 owned and operated communities, Vocal enables creators to connect to their ideal audiences and to partner with the brands that want to reach those audiences. For more information, the content of which is not part of this press release:

Creatd: https://creatd.com ;
Creatd IR: https://investors.creatd.com ;
Vocal Platform: https://vocal.media ;
Investor Relations Contact: ir@creatd.com

Forward-Looking Statements

Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “intends,” “plans,” “believes” and “projects”) may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings.

∗∗∗ Financial Statements Follow ∗∗∗

Creatd, Inc.

Condensed Consolidated Balance Sheet

September 30, 2020
(unaudited)

December 31,
2019

Assets

Current Assets

Cash

$         2,897,385

$            11,637

Prepaid expenses

4,127

Account receivable, net

90,319

50,849

Note receivable – related party

11,450

11,450

Marketable securities

200,000

Total Current Assets

3,199,154

78,063

Property and equipment, net

40,032

42,363

Intangible assets

992,455

1,087,278

Goodwill

1,035,795

1,035,795

Deposits and other assets

197,243

16,836

Operating lease right of use asset

258,249

311,711

Total Assets

$          5,722,928

$         2,572,046

Liabilities and Stockholders ‘ Equity (Deficit)

Current Liabilities

Accounts payable and accrued liabilities

$          1,339,024

$        1,763,222

Demand loan

50,000

225,000

Convertible Notes – related party, net of debt discount

20,387

Convertible Notes, net of debt discount and issuance costs

174,469

2,896,425

Current portion of operating lease payable

79,816

105,763

Notes payable, related party, net of debt discount

3,295

5,129,342

Notes payable, net of debt discount and issuance costs

990,122

660,000

Unrecognized tax benefit

68,000

68,000

Deferred revenue

37,421

50,691

Warrant liability

10,000

Total Current Liabilities

2,742,147

10,928,830

Non-current Liabilities:

Note payable

401,764

Operating lease payable

176,623

201,944

Total Non-current Liabilities

578,387

201,944

Total Liabilities

3,320,534

11,130,774

Commitments and contingencies

Stockholders’ Equity (Deficit)

Series A Preferred stock, $0.001 par value,0 and 31,581 issued and outstanding respectively

Series B Preferred stock, $0.001 par value,0 and 8,063 issued and outstanding, respectively

Series D Preferred stock, $0.001, 0 and 914 shares issued and outstanding respectively

Common stock, $0.001 par value: 100,000,000 authorized shares; 8,662,745 issued and 8,653,395 outstanding as of September 30, 2020 and 3,059,646 issued and 3,006,362 outstanding at December 31, 2019

8,607

3,059

Additional paid-in capital

67,812,570

36,391,819

Accumulated deficit

(65,302,489)

(44,580,437)

Accumulated other comprehensive income (loan)

(28,790)

(5,995)

Less: Treasury stock, 9,350 and 53,283 shares, respectively

(87,560)

(367,174)

Total Stockholders ‘ Equity (Deficit)

2,402,394

(8,558,728)

Total Liabilities and Stockholders ‘ Equity (Deficit)

$         5,722,928

$          2,572,046

Creatd, Inc.

Condensed Consolidated Statements of Operations

(unaudited)

Three Months ended
September 30

Nine Months ended
September 30

2020

2019

2020

2019

Net revenues

$        424,814

$       91,386

$      1,040,496

$     132,901

Cost of revenues

Gross margin

424,814

91,386

1,040,496

132,901

Operating expenses

Compensation

5,203,931

531,502

7,470,629

1,803,113

Consulting fees

739,503

412,394

2,291,609

810,025

Research and development

158,528

11,349

329,803

366,247

General and administrative

1,346,716

792,664

3,333,520

1,917,154

Total operating expenses

7,448,678

1,747,909

13,425,561

4,896,539

Loss from operations

(7,023,864)

(1,656,532)

(12,385,065)

(4,763,638)

Other income (expenses)

Other income

437,657

515,442

Interest expense

(512,650)

(164,439)

(1,379,386)

(329,040)

Accretion of debt discount and issuance cost

(6,370,557)

(111,027)

(6,697,778)

(228,017)

Settlement of vendor liabilities

(126,087)

Gain on marketable securities

(17,495)

(7,453)

Loss on extinguishment of debt

(88,734)

(2,022)

(623,774)

(83,171)

Gain settlement of debt

470

Other income (expenses), net

(6,551,778)

(277,488)

(8,318,566)

(640,228)

Loss before income tax provision

(13,575,643)

(1,934,011)

(20,703,631)

(5,403,866)

Income tax provision

Net loss

$ (13,575,643)

$ (1,934,011)

$ (20,703,631)

$ (5,403,866)

Deemed dividend

18,421

18,421

Inducement expense

(7,628)

Net loss attributable to common shareholders

(13,594,064)

(1,934,011)

(20,722,052)

(5,396,238)

Other comprehensive income

Currency translation gain (loss)

5,735

(22,795)

Comprehensive loss

(13,569,908)

(1,934,011)

(20,726,426)

(5,396,238)

Per-share data

Basic and diluted loss per share

$         (3.20)

$      (0.65)

$         (5.91)

$       (2.05)

Weighted average number of common shares outstanding

4,254,300

2,966,440

3,506,393

2,633,406

Monday, November 16th, 2020 Uncategorized Comments Off on $CRTD Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2020

$AZRX Physical Fitness in Children is More Important Than BMI

new study by the University of Georgia has shown that while grown-ups exercise mostly to lose weight, children should exercise to build endurance, or how well their bodies can handle long periods of exercise. Physical education for children should be centered on motivating children to be active, educating them on the benefits of exercise and improving their physical skills.

According to the authors of the study, strengthening children’s cardiorespiratory endurance should be the main goal in exercise for children. Even children who are overweight can still achieve the recommended one hour of moderate to vigorous physical activity every day. The BMI of a person is measured to find out if he or she is overweight, obese or normal weight. The measurement is said to indicate that children who are more active in PE are more likely to remain active after school.

Lead author of the study, associate professor in the Mary Frances Early College of Education Sami Yli-Piipari, explained that the research had demonstrated that even in young children, those who are fitter with regard to cardiorespiratory endurance took part in more intense physical activities. He also stated that children who were a little overweight could still be relatively fit and that the weight didn’t really matter.

The study involved 450 kids, between the ages of 10-12, who participated in one and a half hours of mandatory physical education (PE) each week. During the day, the children wore an accelerometer on their right hip to record the total physical activity for a week. Additionally, simple tests, such as being able to do a crunch or a modified or regular push-up, were used to find out the children’s mastery of physical skills. The researchers also evaluated whether students took part in PE because it was mandatory or because they enjoyed it.

Yli-Piipari added that PE mattered, as the activities helped students not only learn skills but also presented them with the opportunity to do something active at a higher level than they normally might after the school day. The study was conducted in Finland, as students in that country have more time allotted to PE classes as their fellow American students. Finnish PE classes focus on the significance of exercise and how to include it into students’ daily activities.

As prior research had already shown, boys tended to be more active when compared to girls. Surprisingly though, motor skills and muscle strength did not depend on activity levels. The researchers discovered that motivation did not play a role in whether a student wanted to take part in PE or whether they enjoyed the PE classes. Those who were generally less active in their down time were found to be children who didn’t take part in after-school activities.

AzurRx BioPharma Inc. (NASDAQ: AZRX) is a biomedical company worthy of your attention. The company is in the business of using recombinant proteins to come up with novel treatments targeting gastrointestinal conditions.

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Monday, November 16th, 2020 Uncategorized Comments Off on $AZRX Physical Fitness in Children is More Important Than BMI

HempFusion Wellness Builds Reputation for Safety in the Global CBD Market, Aims to IPO on TSX Exchange

  • HempFusion Wellness, Inc. is a health and wellness company developing the power of whole-food hemp nutrition through more than 40 products currently on store shelves
  • The company is focused on industry safety and quality standards through regulatory compliance, and is currently participating in a real world consumer study to establish the safety of daily cannabidiol (“CBD”) use in regard to liver function
  • HempFusion has filed a preliminary prospectus for a planned initial public offering of its stock in Canada and a listing on the Toronto Stock Exchange
  • Despite a reduction in hemp farm acreage this year following last year’s glut, market watchers anticipate the industrial hemp market is expected to reach $22 billion by 2022

The U.S. election this month demonstrated the lasting potential of the market for cannabis-derived products when five states joined the march toward legalizing marijuana for recreational or medicinal uses (https://nnw.fm/41UKq). Despite a variety of challenges that plagued the nascent hemp industry in 2019 as well as the contentious societal debates over the COVID-19 pandemic’s impact on everyday life and the choices for president, cannabis’ hemp and marijuana offshoots seem to have transcended the upheaval that has defined 2020.

Denver-based HempFusion Wellness has continued to build its own movement toward market success in the cannabis wellness industry, developing 46 products that are currently on shelves while establishing the second-largest cash position in its sector without debt. And in October the company announced a preliminary prospectus with the securities regulatory authorities in Canada, excepting the Quebec province, for a proposed initial public offering of common shares and listing on the Toronto Stock Exchange that makes HempFusion the first US-based cannabidiol (“CBD”) company to apply to list on the TSX (https://nnw.fm/LTOfk).

HempFusion Wellness has invested heavily in regulatory compliance in order to meet and exceed the safety and quality standards established not only by government officials, but selective consumers and retailers as well. As a member of the U.S. Hemp Roundtable, the company works with other coalition members in advancing the safety of hemp and CBD products.

The company’s focus on regulatory compliance has in turn opened doors to major food and drug mass market retailers. HempFusion has its eye on five channels — natural health retail outlets, Internet-based commerce, big box chains and other mass markets, doctor / care provider referrals and convenience stores.

HempFusion’s proprietary Whole Food Panoramic Full-Spectrum Hemp Complex products present solutions for basic, specific needs such as sleep, energy and stress. Its offerings include tinctures and capsules, as well as FDA listed over-the-counter (“OTC”) products designed to combat pain, eczema, acne and skin aging, and wounds.

HempFusion is one of 12 companies working to capture real world evidence from consumers on how they use CBD products and how their bodies react to those products, with a primary focus on whether daily use is safe for the liver in response to questions raised by the U.S. Food and Drug Administration (https://nnw.fm/C5axg).

“We believe this real world evidence is important to the FDA and could be used to guide policy moving forward,” Patrick McCarthy, the CEO of life sciences researcher ValidCare, which is conducting the scientific study, stated.

Licensed hemp farm acreage decreased on a year-over-year basis in 2020 for the first time since the 2014 Farm Bill established a national hemp pilot program, according to industry watchers (https://nnw.fm/y3z2h). The downward movement was driven by regulatory uncertainty and a vast oversupply of hemp last year in the wake of the previous winter’s updating of the 2014 bill to provide broader legalization to hemp as an agricultural commodity. It is important to note, HempFusion is not a cultivator and is instead focused on product R&D, increased distribution and consumer safety. Nevertheless, Brightfield Group has projected the hemp CBD market to reach $22 billion by 2022 (https://nnw.fm/3Z5Fi).

For more information, visit the company’s website at www.HempFusion.com/Corporate-Information.

NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://nnw.fm/HempFusion

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, November 16th, 2020 Uncategorized Comments Off on HempFusion Wellness Builds Reputation for Safety in the Global CBD Market, Aims to IPO on TSX Exchange

Knightscope, Inc.’s AI-equipped Security Robots Building Confidence in Law Enforcement Sector

  • Knightscope is building a clientele for its robotic security force models, including about dozens of clients from Fortune 1000 companies, to law enforcement agencies, hospitals, casinos, water utilities, malls and manufacturing plants
  • The company’s robots use artificial intelligence to navigate indoor and outdoor areas that are Americans with Disabilities Act compliant, and can be monitored with a simple browser and Internet connection
  • The robots record data and use recognition features to assess potentially significant elements such as human activities, thermal changes and license plate information
  • The privately held company is backed by more than 16,000 investors and four major corporations, and has raised more than $70 million since its founding in 2013
  • Knightscope has now secured its first agreement with the federal government for a project at a Texas Veterans Administration hospital, which the company hopes may lead to more federal projects in the future

A series of publicized incidents in which police officers used violence against racial minorities during the past few years, generating controversy because of their tactics, has led to a nationwide debate about the role of law enforcement and the potential need for police reform.

The debate has extended beyond the purview of street-patrolling officers in metropolitan areas, as demonstrated by the recent announcement from the University of Oregon that it will convert several vacant armed police officer positions into frontline, unarmed community service officer positions — an effort to develop more confidence in campus security forces while retaining a backup armed police presence for potentially violent circumstances (https://nnw.fm/EFhQ7).

Autonomous Security Robot developer Knightscope is pursuing a distinct strategy for generating confidence in protective forces. The company’s roving, artificial intelligence-equipped sentries are designed to create a qualified security presence not unlike the one used at the university, presenting a non-threatening patrol that is nonetheless a capable, critical frontline deployment in combating criminal forces.

Knightscope’s indoor and outdoor-capable models feature 360-degree eye-level HD streaming video, speakers for recorded or live communication, and recognition features that detect people, faces, license plates, thermal fluctuations and automatic signals.

A whimsical CG-animated video of the robots arriving at a train station celebrates the company’s first deployment on behalf of the federal government with an agreement to use them at the Audie L. Murphy Memorial Veteran’s Hospital in San Antonio, Texas (https://nnw.fm/vNQTY). Knightscope is hopeful its performance there will lead to additional government projects in the future.

“One of the more obvious roles for robots in security is that they’re highly productive in repetitive and dangerous tasks,” Stacy Stephens, the vice president of marketing and sales, said in another video that explains how the robots work (https://nnw.fm/6qzhI). “So if you can imagine putting a human being into a place where they’re doing the same thing over and over and over again, they become ineffective very, very quickly. You can also imagine having to put somebody in the line of fire in a dangerous situation — a robot doesn’t care about that. You put them in there instead of a human being, you make it safer and much more productive.”

Human operators can then monitor and review the data the sentries collect at will. The robots function in Americans with Disabilities Act-compliant areas, using LiDAR for navigation in combination with sonar and GPS to navigate. They also retain video data for two weeks, which is accessible with a simple Chrome browser and Internet connection. Their mere presence may serve as a deterrent for problems.

The company estimates that the robots operate in a price range of about $4 to $11 an hour, which makes their service less expensive than their human counterparts after they’ve been purchased. Clients include about Fortune 1000 clients, such as Samsung and Citizens Bank, five major hospitals plus law enforcement agencies.

Using equity crowdfunding, Knightscope has raised millions of dollars to support its operations from a larger pool than most big money companies might seek and is now raising growth capital to scale up its operations.

“A lot of larger institutional investors will say, … ‘You have 7,000 investors, they must be driving you mad,’” CEO William Santana Li said during an interview earlier this year with StartEngine strategic adviser Kevin O’Leary, aka Mr. Wonderful (https://nnw.fm/0aRRS). “I tell them, ‘Listen, chief security officers of major corporations are investors of ours. NYPD detectives, FBI, CIA, DHS, vice presidents of leasing of major malls. I would never dare trade out our 7,000 investors for three or four guys (it’s mostly guys) sitting around a table asking the wrong questions, worried about all the wrong things.”

Knightscope is now backed by more than 16,000 investors and four major corporations, having raised more than $70 million since it began in 2013.

For more information, visit the company’s website at www.Knightscope.com.

Visit www.Knightscope.com/Invest for a summary of Knightscope as an investment, with a blue Instant Messaging button for direct contact with their CEO.

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://nnw.fm/Knight

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, November 16th, 2020 Uncategorized Comments Off on Knightscope, Inc.’s AI-equipped Security Robots Building Confidence in Law Enforcement Sector

$VTGN Announces Q2 Results, Provides Update on CNS Pipeline and Business Progress

VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, today reported its financial results for the fiscal 2021 second quarter ended September 30, 2020. In addition, the company provided an update on its CNS pipeline and business progress. “We see a significant rise in mental health concerns as the global COVID-19 pandemic continues to impact the daily lives of millions of individuals. We are committed to developing innovative therapies that provide relief to those suffering from anxiety and depression, and we are working diligently towards that goal,” said VistaGen CEO Shawn Singh. “We are making significant progress in preparing PH94B for launch of a pivotal Phase 3 study for acute treatment of anxiety in adults with social anxiety disorder in the second quarter of 2021. After reaching consensus with the FDA on the key components of the study design, it will be very similar to the statistically significant Phase 2 study of PH94B in social anxiety disorder. We are also working with the FDA to finalize details for our Phase 2A study of PH94B in adjustment disorder, which we are planning to initiate in early 2021.”

To view the full press release, visit http://ibn.fm/c1QvN

About VistaGen Therapeutics

VistaGen is a clinical-stage biopharmaceutical company developing and commercializing differentiated new generation medicines that go beyond the current standard of care for anxiety, depression and other CNS disorders. Each of VistaGen’s three drug candidates has a differentiated mechanism of action, an exceptional safety profile in all studies to date, and therapeutic potential in multiple CNS markets. For more information, please visit www.VistaGen.com and connect with VistaGen on TwitterLinkedIn and Facebook.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at http://ibn.fm/VTGN

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Friday, November 13th, 2020 Uncategorized Comments Off on $VTGN Announces Q2 Results, Provides Update on CNS Pipeline and Business Progress

$WTER to Host Teleconference to Discuss Q2 2021 Results

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, on Thursday announced its plans to host a teleconference with investors and analysts to review fiscal second-quarter 2021 financial results. President and CEO Richard Wright and Chief Financial Officer David Guarino will host the call at 5:00 PM Eastern Time on Monday, Nov. 16, 2020. In addition, the company will issue a press release outlining its financial results and outlook after the market close on Nov. 16, 2020. Interested parties may join the teleconference by dialing 877-407-3088 (U.S. and Canada) or 201-389-0927 (International / Outside of the U.S. and Canada). Participants are asked to dial in five to 10 minutes before the scheduled call time.

To view the full press release, visit: https://cnw.fm/HuHdy

About The Alkaline Water Company

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in seven unique all-natural flavors with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products includes both the company’s lab-tested, full-spectrum hemp salves, balms, lotions, essential oils and bath salts, along with broad-spectrum hemp beverage shots, powder packs, oil tinctures, capsules and gummies. To learn more about the company, visit www.A88CBD.com and www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Friday, November 13th, 2020 Uncategorized Comments Off on $WTER to Host Teleconference to Discuss Q2 2021 Results

$SGLB Investor Summit Group Releases Lineup of 77 Public Companies to Present at Virtual Fall Event

The Investor Summit Group on Thursday released further details for its Virtual Fall Summit, which is slated to take place from Nov. 16-18, 2020. The event will connect 77 presenting small and microcap companies with distinguished investors from around the globe. Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF)Sigma Labs Inc. (NASDAQ: SGLB) and Trxade Group Inc. (NASDAQ: MEDS) are among the full list of companies scheduled to present at the Fall Investor Summit. Please refer to the update for a complete list of issuers, as well as webcasting links to view the presentations.

To view the full press release, visit http://ibn.fm/Ce9NL

About Investor Summit Group

The Investor Summit Group (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Having produced successful conferences over the past five years, the upcoming event will be the third virtual edition added to Investor Summit’s growing portfolio where hundreds of high-quality meetings between executives and investors will take place over three days. The Investor Summit Group prides itself on building community and providing a platform for the industry and looks forward to launching new features at the upcoming Fall Summit such as virtual networking, panels and a stock pitch competition to promote endless connections in a virtual format. To register for the upcoming Investor Summit, visit www.InvestorSummitGroup.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Friday, November 13th, 2020 Uncategorized Comments Off on $SGLB Investor Summit Group Releases Lineup of 77 Public Companies to Present at Virtual Fall Event

$PCSA Announces Q3 2020 Results, Provides Corporate Update

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products intended to provide treatment for and improve the survival and/or quality of life for patients with unmet medical needs or no alternative treatment, on Thursday released its financial results for the third quarter of 2020. In addition, Processa provided a business update via conference call, for which the replay may be accessed at https://ibn.fm/BdxSB or by dialing 877-481-4010 (Toll-free) or 919-882-2331 (International) and entering replay passcode: 38528. “The third quarter was a period of tremendous value creation. Over that time, we in-licensed important clinical drug candidates PCS12852 and PCS6422, uplisted to Nasdaq and closed a $19.2 million public offering,” Dr. David Young, CEO and chairman of Processa, stated in the press release. “Due to those achievements, we now have sufficient funds to complete three trials for three distinct markets, each exceeding $1 billion. Importantly, we are developing products for which existing clinical evidence of efficacy has already been established. With key milestones to announce over the next 12-18 months, including interim data for PCS6422 in 3Q21 and PCS499 in 4Q21, we are excited about the near-term opportunity of increasing shareholder value.”

To view the full press release, visit http://ibn.fm/VpuUK

About Processa Pharmaceuticals Inc.

The mission of Processa is to develop products for which existing clinical evidence of efficacy has already been established for unmet or under-served medical conditions for which patients need treatment options that improve survival and/or quality of life. The company used these criteria to develop its pipeline programs in order to achieve high-value milestones effectively and efficiently using the Processa Regulatory Science approach. The members of the Processa development team have been involved with more than 30 drug approvals by the FDA (including drug products targeted to orphan disease conditions) and more than 100 FDA meetings throughout their careers. For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at http://ibn.fm/PCSA

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Friday, November 13th, 2020 Uncategorized Comments Off on $PCSA Announces Q3 2020 Results, Provides Corporate Update

$PCSA Biodegradable Implantable Sensors Can Monitor Body Functions

Using biodegradable materials, an international team of scientists has designed a flexible gas sensor that is highly sensitive and can be implanted in the human body. The sensor, which monitors a patient’s condition during and after medical procedures, biodegrades safely after its use has been exhausted and is absorbed by the body. This is a much better sensor than the sensors currently in use. The current sensors are not only expensive, but they can also be dangerous and uncomfortable.

Researchers designed this implantable sensor that can monitor different forms of nitrogen dioxide and nitric oxide gas in the body. These gases play a beneficial although sometimes harmful role in a person’s health, hence the need to monitor them. For instance, nitric oxide, which is a highly reactive gas produced in the human body naturally, widens or relaxes blood vessels, thus allowing nutrients and oxygen to circulate in the body, enhancing blood flow.

An assistant professor in the Department of Engineering Science and Mechanics at Penn StateDr. Huanyu Cheng, states that nitric oxide transforms into nitrogen dioxide when it’s exposed to oxygen and notes that environmental exposure to nitrogen dioxide is connected with the progression of conditions such as chronic obstructive pulmonary disease.

The study findings were reported in the “NPG Asia Materials.” The sensor was made from materials that weren’t just biodegradable but also stretchable. Cheng elaborated on how the team decided on its sensor design, explaining that devices currently being used are not as accurate as a device that was implanted; today’s devices are also bulky and are used outside the body. What few implantable devices available need to be removed, which may result in another operation.

According to the researchers, all the components used to make the sensors are biodegradable in bodily fluids and water but are still functional enough to record information on bodily gas levels. The sensor’s functional materials are made from silicon because it’s extremely sensitive to nitric oxide while its conductors are made out of magnesium. The materials are said to dissolve at a slow pace that allows the sensors to continue functioning in the patient’s body during their recovery period.

The sensor was tested in aqueous solutions and humid conditions to demonstrate that it could perform steadily in the body’s harsh conditions. The team of researchers note that in the future, they will work toward designing integrated systems that can monitor other body functions for various disease applications and for healthy aging.

An entity you need to pay attention to within the biomedical industry is Processa Pharmaceuticals Inc. (NASDAQ: PCSA). This firm specializes in identifying medical needs for which clinical efficacy proof exists regarding possible remedies. Processa then develops those remedies and brings them to market.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Friday, November 13th, 2020 Uncategorized Comments Off on $PCSA Biodegradable Implantable Sensors Can Monitor Body Functions

$NETE Mullen Technologies Positioned at the Forefront of Reduced EV Manufacturing Costs

Net Element (NASDAQ: NETE) is transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer through its merger with privately-held Mullen Technologies Inc. Timing looks optimal for the transition as new research from investment bank UBS finds that the cost to manufacture EVs may be the same as the cost for regular models within the next four years (https://ibn.fm/DW8fZ). This news bodes well for Net Element and Mullen. A recent article discussing this reads, “Mullen recently announced its own plans to start work on a manufacturing facility as well as accept pre-orders for its M05 fully electric SUV. ‘We are excited to begin the build-out of our pilot facility and pre-sales of our MX-05 SUV in October,’ said Mullen Technologies chairman and CEO David Michery. ‘We plan on completing the build-out by April 2021 and to begin assembly of certification prototypes by July 2021. These vehicles will be used for homologation, which is expected to take 16 months and be completed by May of 2022, at which time we expect to begin delivering the first vehicles to the public.’”

To view the full article, visit https://ibn.fm/wIZWj

About Net Element Inc.

Net Element operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the United States and selected emerging markets. In the U.S., the company aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, its cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest-growing companies in North America on Deloitte’s 2017 Technology Fast 500(TM). In 2017 Net Element was recognized by “South Florida Business Journal” as one of 2016’s fastest-growing technology companies. Further information is available at www.NetElement.com.

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Friday, November 13th, 2020 Uncategorized Comments Off on $NETE Mullen Technologies Positioned at the Forefront of Reduced EV Manufacturing Costs